We proudly ship across Canada to qualified research institutions and laboratories
These are not FDA approved and may not be available in your state
A typical transition timeline might look like this: Weeks 1-4: Start tirzepatide 2.5 mg weekly while maintaining phentermine at current dose Weeks 5-8: Increase tirzepatide to 5 mg weekly, reduce phentermine to 15 mg daily (if currently on a higher dose) Weeks 9-12: Increase tirzepatide to 7.5 mg weekly, begin tapering phentermine to every other day Week 13+: Discontinue phentermine, continue tirzepatide titration as needed This is a general framework, not a prescription
Unsuccessful Diet Attempts If you have tried various diets and weight loss programs without lasting success, medical weight loss offers a medically-proven approach to achieve significant weight loss
Oral glutathione (250500 mg/day) has shown potential to reduce skin pigmentation and improve brightness over 412 weeks in healthy adults
Unlike traditional weight loss drugs that focus on just one pathway, tirzepatide engages both GLP-1 and GIP receptors